Hemorrhagic	hemorrhagic	O	DISEASE	OTHERS	I
cystitis	cystitis	O	DISEASE	OTHERS	I
complicating	complicating	O	O	O	O
bone	bone	O	O	O	O
marrow	marrow	O	O	O	O
transplantation	transplantation	O	O	O	O
.	.	O	O	O	O

Hemorrhagic	hemorrhagic	O	DISEASE	OTHERS	I
cystitis	cystitis	O	DISEASE	OTHERS	I
is	is	O	O	O	O
a	a	O	O	O	O
potentially	potentially	O	O	O	O
serious	serious	O	O	O	O
complication	complication	O	O	O	O
of	of	O	O	O	O
high-dose	high-dose	O	O	O	O
cyclophosphamide	cyclophosphamide	CHEMICALS	O	OTHERS	I
therapy	therapy	O	O	O	O
administered	administered	O	O	O	O
before	before	O	O	O	O
bone	bone	O	O	O	O
marrow	marrow	O	O	O	O
transplantation	transplantation	O	O	O	O
.	.	O	O	O	O

As	as	O	O	O	O
standard	standard	O	O	O	O
practice	practice	O	O	O	O
at	at	O	O	O	O
our	our	O	O	O	O
institution	institution	O	O	O	O
,	,	O	O	O	O
patients	patients	O	O	O	O
who	who	O	O	O	O
are	are	O	O	O	O
scheduled	scheduled	O	O	O	O
to	to	O	O	O	O
receive	receive	O	O	O	O
a	a	O	O	O	O
bone	bone	O	O	O	O
marrow	marrow	O	O	O	O
transplant	transplant	O	O	O	O
are	are	O	O	O	O
treated	treated	O	O	O	O
prophylactically	prophylactically	O	O	O	O
with	with	O	O	O	O
forced	forced	O	O	O	O
hydration	hydration	O	O	O	O
and	and	O	O	O	O
bladder	bladder	O	O	O	O
irrigation	irrigation	O	O	O	O
.	.	O	O	O	O

In	in	O	O	O	O
an	an	O	O	O	O
attempt	attempt	O	O	O	O
to	to	O	O	O	O
obviate	obviate	O	O	O	O
the	the	O	O	O	O
inconvenience	inconvenience	O	O	O	O
of	of	O	O	O	O
bladder	bladder	O	O	O	O
irrigation	irrigation	O	O	O	O
,	,	O	O	O	O
we	we	O	O	O	O
conducted	conducted	O	O	O	O
a	a	O	O	O	O
feasibility	feasibility	O	O	O	O
trial	trial	O	O	O	O
of	of	O	O	O	O
uroprophylaxis	uroprophylaxis	O	O	O	O
with	with	O	O	O	O
mesna	mesna	CHEMICALS	O	OTHERS	I
,	,	O	O	O	O
which	which	O	O	O	O
neutralizes	neutralizes	O	O	O	O
the	the	O	O	O	O
hepatic	hepatic	O	O	O	O
metabolite	metabolite	O	O	O	O
of	of	O	O	O	O
cyclophosphamide	cyclophosphamide	CHEMICALS	O	OTHERS	I
that	that	O	O	O	O
causes	causes	O	O	O	O
hemorrhagic	hemorrhagic	O	DISEASE	OTHERS	I
cystitis	cystitis	O	DISEASE	OTHERS	I
.	.	O	O	O	O

Of	of	O	O	O	O
97	97	O	O	O	O
patients	patients	O	O	O	O
who	who	O	O	O	O
received	received	O	O	O	O
standard	standard	O	O	O	O
prophylaxis	prophylaxis	O	O	O	O
,	,	O	O	O	O
4	4	O	O	O	O
had	had	O	O	O	O
symptomatic	symptomatic	O	O	O	O
hemorrhagic	hemorrhagic	O	DISEASE	OTHERS	I
cystitis	cystitis	O	DISEASE	OTHERS	I
.	.	O	O	O	O

In	in	O	O	O	O
contrast	contrast	O	O	OTHERS	I
,	,	O	O	O	O
two	two	O	O	O	O
of	of	O	O	O	O
four	four	O	O	O	O
consecutive	consecutive	O	O	O	O
patients	patients	O	O	O	O
who	who	O	O	O	O
received	received	O	O	O	O
mesna	mesna	CHEMICALS	O	OTHERS	I
uroprophylaxis	uroprophylaxis	O	O	O	O
before	before	O	O	O	O
allogeneic	allogeneic	O	O	O	O
bone	bone	O	O	O	O
marrow	marrow	O	O	O	O
transplantation	transplantation	O	O	O	O
had	had	O	O	O	O
severe	severe	O	O	O	O
hemorrhagic	hemorrhagic	O	DISEASE	OTHERS	I
cystitis	cystitis	O	DISEASE	OTHERS	I
for	for	O	O	O	O
at	at	O	O	O	O
least	least	O	O	O	O
2	2	O	O	O	O
weeks	weeks	O	O	O	O
.	.	O	O	O	O

Because	because	O	O	O	O
of	of	O	O	O	O
this	this	O	O	O	O
suboptimal	suboptimal	O	O	O	O
result	result	O	O	O	O
,	,	O	O	O	O
we	we	O	O	O	O
resumed	resumed	O	O	O	O
the	the	O	O	O	O
use	use	O	O	O	O
of	of	O	O	O	O
bladder	bladder	O	O	O	O
irrigation	irrigation	O	O	O	O
and	and	O	O	O	O
forced	forced	O	O	O	O
hydration	hydration	O	O	O	O
to	to	O	O	O	O
minimize	minimize	O	O	O	O
the	the	O	O	O	O
risk	risk	O	O	O	O
of	of	O	O	O	O
hemorrhagic	hemorrhagic	O	DISEASE	OTHERS	I
cystitis	cystitis	O	DISEASE	OTHERS	I
.	.	O	O	O	O

